Safety and Efficacy of Combination Therapy with Pegylated Interferon Alpha-2a and Ribavirin in Treating Patients with Chronic Hepatitis C and Beta-Thalassaemia Major: A Greek Single-Center Experience

Publisher： Karger

E-ISSN： 1421-9662|126|4|231-233

ISSN： 0001-5792

Source： Acta Haematologica, Vol.126, Iss.4, 2011-09, pp. : 231-233

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin

By  

Psychotherapy and Psychosomatics, Vol. 83, Iss. 5, 2014-08 ,pp. : 308-309

Karger

Access to resources Recommend Favorite

Pegylated Interferon plus Ribavirin Combination Therapy for Chronic Hepatitis C in Patients with Congenital Coagulation Disorders

By  

Acta Haematologica, Vol. 120, Iss. 2, 2008-10 ,pp. : 63-69

Karger

Access to resources Recommend Favorite

An inadequate dose of ribavirin is related to virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin

By Ogawa Eiichi  

Journal of Infection and Chemotherapy, Vol. 18, Iss. 5, 2012-10 ,pp. : 689-697

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and Tolerability of Pegylated Interferon-α2a plus Ribavirin versus Pegylated Interferon-α2b plus Ribavirin in Treatment-Naive Chronic Hepatitis C Patients

By  

Intervirology, Vol. 53, Iss. 3, 2010-01 ,pp. : 146-153

Karger

Access to resources Recommend Favorite

Mutations in non-structural 5A and rapid viral response to pegylated interferon-α-2b plus ribavirin therapy are associated with therapeutic efficacy in patients with genotype 1b chronic hepatitis C

By                                                  

International Journal of Molecular Medicine, Vol. 30, Iss. 5, 2012-01 ,pp. : 1048-1052

Spandidos Publications

Access to resources Recommend Favorite